| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.067 | 0.3 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |